Metabolic disorders such as Ca, P, and PTH in vivo caused by chronic renal impairment will lead to cardiovascular diseases and fractures, posing a great threat to human life and health.[15] However, the optimal strategy for the treatment of CKD-MBD remains controversial. This evidence concerns the gene PTH and Marchiafava-Bignami disease.